Jubbonti
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Jubbonti, covering 2025-11-27 to 2025-11-27. Get the full timeline:
Most recent: EMA Authorised: Jubbonti (denosumab) — Sandoz GmbH
1 regulatory and trial event tracked for Jubbonti, covering 2025-11-27 to 2025-11-27. Get the full timeline:
Most recent: EMA Authorised: Jubbonti (denosumab) — Sandoz GmbH